Innovations in Prostate Treatment and Diagnostics

Working with front-line clinicians, product designers, and developers, MedicaMetrix aims to deliver better solutions for prostate care. Our innovative device, ProstaMetrix, aims to improve the process of diagnosing and treating prostate cancer.

Download the Investor Deck

and learn more about this investment opportunity!

The Current State of Prostate Health Management

Currently, there is no cost-effective and non-invasive way to distinguish between aggressive and indolent prostate cancer. There is a critical need for low cost, more accurate prostate cancer screening in the early stages.

One in eight men will be
diagnosed with prostate cancer

Prostate cancer is the
2nd LEADING CAUSE OF CANCER DEATH
in American men, behind onlylung cancer

Next Generation Cancer Screening

ProstaMetrix is a portable, physician’s office medical tech device that turns a digital rectal exam into a next generation cancer screening tool. The ProstaMetrix device makes it possible to treat multiple forms of prostate disorder and diseases in a low-cost, point-of-care and real-time procedure.

Benefits of ProstaMetrix:

  • Less invasive diagnostic option for patients
  • An efficient way for patients and physicians to
    monitor the progression of the disease
  • Lower costs of diagnosis for patients
  • Increased speed in diagnostic information available for physicians

The Investment Opportunity

Patented, innovative and novel MedTech

Certified for use in UK, Euro Zone and India ( FDA approval likely in late 2022)

Certified for use in UK, Euro Zone and India ( FDA approval likely in late 2022)

Diverse, experienced management team with start-up company knowhow

Developed, designed and engineered in the U.S.

    >>> View Our Offering Circular

MedicaMetrix is an innovative Medtech company providing innovative solutions for prostate care and management. Through a Regulation A+ filing, an investment in MedicaMetrix is available to anyone seeking to become an investor in the Medtech and Devices markets.

 

Offering Type:  Reg. A+ Equity Crowdfunding     

Min. Investment: $750 

Price Per Share:  $5          

DOWNLOAD INVESTOR DECK
Preloader image